Clinical Trial Update: Symptom Adapted Therapy in GERD Patients [Phase 4]

View source ↗

Summary

This entry reports a completed Phase 4 clinical trial on symptom-adapted therapy for gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease | Phase 4 | Status: COMPLETED